Eye-tracking startup that helps diagnose concussions gets FDA’s OK


Oculogica Inc., a startup launched by Twin Cities neurosurgeon Dr. Uzma Samadan, has received a regulatory clearance allowing it to market its eye-tracking device as an aid for diagnosing concussion.

Previous Biotech startup emerges from stealth with $65M to tackle lung cancer
Next Triad pharmaceutical company gets tentative approval for drug treating MS